Does BENRALIZUMAB Cause Neoplasm malignant? 112 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Neoplasm malignant have been filed in association with BENRALIZUMAB (FASENRA). This represents 0.7% of all adverse event reports for BENRALIZUMAB.
112
Reports of Neoplasm malignant with BENRALIZUMAB
0.7%
of all BENRALIZUMAB reports
6
Deaths
19
Hospitalizations
How Dangerous Is Neoplasm malignant From BENRALIZUMAB?
Of the 112 reports, 6 (5.4%) resulted in death, 19 (17.0%) required hospitalization, and 2 (1.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENRALIZUMAB. However, 112 reports have been filed with the FAERS database.
What Other Side Effects Does BENRALIZUMAB Cause?
Asthma (2,457)
Dyspnoea (1,604)
Death (1,336)
Drug ineffective (1,266)
Cough (793)
Headache (788)
Product dose omission issue (713)
Pneumonia (710)
Wheezing (619)
Malaise (514)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which BENRALIZUMAB Alternatives Have Lower Neoplasm malignant Risk?
BENRALIZUMAB vs BENSERAZIDE
BENRALIZUMAB vs BENSERAZIDE\LEVODOPA
BENRALIZUMAB vs BENZALKONIUM
BENRALIZUMAB vs BENZOCAINE
BENRALIZUMAB vs BENZODIAZEPINE